Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-05 Option Award |
2024-06-05 4:19 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director |
50,000 | $0 | 107,500 (Direct) |
View |
2023-06-07 Option Award |
2023-06-07 5:02 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director |
42,500 | $0 | 57,500 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 5:15 pm |
2022-06-08 2032-06-08 |
Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director |
25,000 | $0 | 40,000 (Direct) |
View |
2022-06-08 Option Award |
2022-06-09 5:15 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director |
15,000 | $2.1 | 40,000 (Direct) |
View |
2021-10-05 Option Award |
2021-10-05 7:50 pm |
N/A 2028-05-15 |
Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director |
62,106 | $0 | 62,106 (Direct) |
View |
2021-06-08 Option Award |
2021-06-08 7:08 pm |
N/A 2031-06-08 |
XERIS PHARMACEUTICALS INC | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director |
11,228 | $0 | 11,228 (Direct) |
View |
2020-06-04 Option Award |
2020-06-04 8:59 pm |
N/A 2030-06-04 |
XERIS PHARMACEUTICALS INC | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director |
11,228 | $0 | 11,228 (Direct) |
View |